Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Megestrol Acetate plus LNG-IUS in young women with early endometrial cancer
NCT03241914Phase 3Completed
- Sponsor
- Fudan University
- Start
- Jul 2017
- Primary completion
- Jun 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of avatrombopag in endometrial cancer (EC), sponsored by Fudan University. Primary endpoint: Pathological response rate at 12 months. Started Jul 2017; status: completed.
02
Drugs
avatrombopag
03
Conditions
endometrial cancer (EC)
Beyond the preview
Go deeper on NCT03241914.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03241914.